Cytotoxicity of 5-fluorouracil released from a bioadhesive patch into uterine cervical tissue

International Journal of Pharmaceutics

Volumn 151, Issue 1, 1997, Pages 69-74

  McCarron, P A ^a   Woolfson, A D ^a   McCafferty, D F ^a   Price, J H ^b   Sidhu, H ^b   Hickey, G I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

5 Fluorouracil; Bioadhesive; Cervical intraepithelial neoplasia; Cytotoxicity; HeLa cells

Indexed keywords

CYTOTOXIC AGENT; FLUOROURACIL;

ADHESION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

EID: 0030976233     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)04888-6     Document Type: Article

References (12)

1. Anderson, M.C. and Hartley, R.B., Cervical crypt involvement by intraepithial neoplasia. Obstet. Gynecol., 55 (1980) 546-550.
2. Ansfield, F.J., Schroeder, J.M. and Curreri, A.R., Five years clinical experience with 5-fluorouracil. J. Am. Med. Assoc., 181 (1962) 295-299.
3. Beresford, J.M., McFaul, S.M. and Moher, D., Laser treatment of cervical intraepithelial neoplasia and the endothelial button. J. Gynecol. Surg., 6 (1990) 111-114.
4. Eaglstein, W.H., Weinstein, G.D. and Frost, P., Fluorouracil: mechanism of action in human skin and actinic keratosis. Arch. Dermatol., 101 (1970) 132-139.
5. Fluhman, C.F., The Cervix Uteri and its Diseases. W.B. Saunders, Philadelphia, 1961.
6. Myers, C.E., Diasio, R., Eliot, H.M. and Chabner, B.A., Pharmacokinetics of the fluoropyrimidines: implications for their clinical use. Cancer Treat. Rev., 3 (1976) 175-183.
7. Pichart, R.M., The growth characteristics in vitro of normal epithelium, dysplasia, and carcinoma-in-situ of the uterine cervix. Cancer Res., 24 (1964) 662-669.
8. Sidhu, H., Price, J.H., Woolfson, A.D., McCafferty, D.F. and McCarron, P.A., A randomised control trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasia. Br. J. Obstet. Gynaecol. (1997) in press.
9. Woolfson, A.D., McCafferty, D.F., McCarron, P.A. and Price, J. H., Liquid scintillation spectrometry of 5-fluorouracil in cervical tissue following topical application of a bioadhesive cervical patch. Pharm. Res., 11 (1994) 1315-1319.
10. Woolfson, A.D., McCafferty, D.F., McCarron, P.A. and Price, J.H., A bioadhesive patch cervical drug delivery system for administration of 5-fluorouracil to cervical tissue. J. Control. Release, 35 (1995a) 49-58.
11. Woolfson, A.D., McCafferty, D.F., McCarron, P.A. and Price, J.H., Autoradiographic imaging of the distribution of 5-fluorouracil through cervical tissue folowing in vitro surface application of a bioadhesive cervical patch. Pharm. Res. 12 (1995b) 676-681.
12. Young, C.W., Ellison, R.R., Sullivan, R.D., Levick, S.N., Kaufman, R., Miller, E., Woldow, I., Escher, G., Li, M.C., Karnofsky, D.A. and Burchenal, J.H., The clinical evaluation of 5-fluorouracil and 5-fluoro-2′-deoxyuridine in solid tumours in adults. Cancer Chemother. Rep., 6 (1960) 17-20.